Innocule

Bhubaneswar, India Founded: 2014 • Age: 12 yrs Minicorn
Chemical solutions for efficient mineral processing are provided.

About Innocule

Innocule is a Chemicals & Materials company based in Bhubaneswar (India) founded in 2014 by Gyan Ranjan Das. Chemical solutions for efficient mineral processing are provided. Innocule has raised $957.94 thousand across 2 funding rounds from investors including Artha99, Pawan Agarwal and Surbhi Sarna. The company has 81 employees. Innocule was last valued at $13.83 million in May 2024. Its Indian entity Innocule Materials And Additives Private Limited reported revenue of β‚Ή36.41 Cr. Innocule offers products and services including Grinex, Oreflo, FAM, Flumix, and Coalmix. Its focus areas include Chemicals and Materials, Diversified Chemicals, Speciality Chemicals and Mining.

Company details

Provider of chemical solutions for efficient mineral processing. It offers customized solutions addressing challenges in mineral operations, such as low-grade ores and processing difficulties. These solutions aim to maximize output and minimize costs by improving grinding efficiency, reducing downtime caused by material stickiness, enhancing filtration production, and reducing impurities in ores. The solutions are designed for integration into existing plants without significant modifications. Products include solutions for improving grinding, filtration, and reducing impurities in various minerals, as well as enhancing coal quality.

  • Headquarters Bhubaneswar, India
  • Employees 81
  • Founders Gyan Ranjan Das
  • Stage Minicorn
  • Sectors
    Chemicals & Materials
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website innocule.com
  • Social LinkedIn
  • Legal Name Innocule Materials And Additives Private Limited
  • Date of Incorporation 11 Nov, 2014
  • Jurisdiction Sarua, Odisha, India
Key Metrics
  • Annual Revenue
    ₹36.41 Cr

    FY 2025 · +27% YoY

  • Net Profit
    ₹1.32 Cr

    FY 2025 · 4% margin

  • EBITDA
    ₹3.10 Cr

    FY 2025 · 9% margin

  • Total Equity Funding
    $957.94K (USD)

    in 2 rounds

  • Latest Funding Round
    $957.94K (USD), Seed

    May 2024

  • Investors
    Artha99

    & 2 more

  • Employee Count
    81

Products & Services of Innocule

Innocule offers a comprehensive portfolio of products and services, including Grinex, Oreflo, FAM, Flumix, and Coalmix.

Grinex
Grinding Efficiency Enhancer

Improves ball mill output and reduces power requirements effectively.

Oreflo
Moisture Management

Reduces raw material stickiness to minimize operational downtime.

FAM
Filtration Aid

Increases production by decreasing moisture in filtration cakes.

Flumix
Ore Purification

Reduces silica and alumina content in various mineral ores.

Coalmix
Coke Enhancement

Improves coke strength and reduces fines during processing.

Dust Suppressant
Environmental Control

Manages dust to enhance safety and operational efficiency.

Funding Insights of Innocule

Innocule has successfully raised a total of $957.94K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $957.94 thousand completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $957,936
  • Total Rounds 2
  • Last Round Seed β€” $957,936
  • Investors Count 3

All 2 funding rounds of Innocule with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2024$957,936Seed$13.83MArtha99
–
Aug 2016Angel Round–Pawan Agarwal
Valuation history
DateValuationStage
May 2024$13.83Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $13.83M (May 2024). 3 investors in total: 1 institutional and 2 angel.

Investors in Innocule

Innocule has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include Artha99, Pawan Agarwal and Surbhi Sarna.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Early-stage venture capital investments in manufacturing ventures in India.
2021artha99.vcChennai, India

Pawan Agarwal

unknown_f1b7398317304b51b

Surbhi Sarna

Founder of nVision Medical, healthcare innovator, active angel investor
unknown_e2629908c2cf46ac9
Premium access

Investor details for Innocule

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Innocule Materials And Additives Private Limited (Innocule)

Innocule Materials And Additives Private Limited is the primary company behind Innocule. The board of Innocule Materials And Additives Private Limited currently have 3 directors; the longest-serving is Gyana Ranjan Das, appointed in 2014. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Gyana Ranjan Das
DIN 07003375
Managing Director11 Nov 201411 yrs 11 moInnocule Materials And Additives Private Limited
Surbhi Sarna
DIN 07003376
Director11 Nov 201411 yrs 11 moInnocule Materials And Additives Private Limited
Gaurav Singh Chauhan
DIN 09134922
Director04 Jun 20215 yrs 5 moInnocule Materials And Additives Private Limited

People of Innocule

1 people are tracked at Innocule (1 in leadership); the tracked headcount is 81.

NameRoleGroup
Gyan Ranjan Das
Co-FounderLeadership
Premium access

Complete people profiles for Innocule

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Innocule

Figures of Innocule Materials And Additives Private Limited, the primary company behind Innocule, for FY 2025. Revenue was ₹36.41 Cr (+27% year on year). Net profit was ₹1.32 Cr (4% margin). EBITDA was ₹3.10 Cr (9% margin). Revenue has grown at a compounded annual rate of +27% over three years and +24% over five years.

  • ₹36.41 CrRevenue · FY 2025 · +27% YoY
  • ₹1.32 CrNet profit · 4% margin
  • ₹3.10 CrEBITDA · 9% margin
  • ₹4.89 CrPaid-up capital
  • 81Employees (provident fund records)
  • +27%Revenue CAGR, 3 years
  • +24%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Innocule Materials And Additives Private Limited are on its company page.

Premium access

Detailed financial statements for Innocule

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Innocule

4 dated milestones of Innocule across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Innocule is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Seed, of $958K.
  4. Milestone Reaches Minicorn status.

Top companies in Core & Diversified Chemicals

3 companies that operate in the same segment as Innocule (Core & Diversified Chemicals) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Specialty chemicals are manufactured through integrated R&D and production processes.
2023Bengaluru, Karnataka, IndiaUSD 72.97 MUSD 23.86 M
Manufactures coal tar and basic industrial chemicals.
1987Kolkata, West Bengal, IndiaUSD 24 MUSD 496.46 M2,480
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Innocule

Innocule was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Innocule is headquartered in Bhubaneswar, India. It is registered at Bhubaneswar, Odisha, India.

Innocule is a funded company, having raised a total of $957.94K across 2 funding rounds to date.

Innocule has 81 employees.

The primary company behind Innocule, Innocule Materials And Additives Private Limited, reported revenue of β‚Ή36.41 Cr for FY 2025, up 27% year on year.

Provider of chemical solutions for efficient mineral processing. It offers customized solutions addressing challenges in mineral operations, such as low-grade ores and processing difficulties. These solutions aim to maximize output and minimize costs by improving grinding efficiency, reducing downtime caused by material stickiness, enhancing filtration production, and reducing impurities in ores. The solutions are designed for integration into existing plants without significant modifications. Products include solutions for improving grinding, filtration, and reducing impurities in various minerals, as well as enhancing coal quality.

Innocule offers Grinex, Oreflo, FAM, Flumix, and 2 more products and services.

Innocule has 3 investors. Key investors include Artha99, Pawan Agarwal, and Surbhi Sarna.

The valuation of Innocule is $13.83M as of May 2024.

Innocule operates through Innocule Materials And Additives Private Limited.

The legal entities of Innocule currently have 3 directors, including Gyana Ranjan Das, Surbhi Sarna, Gaurav Singh Chauhan.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available